Anne Mackie, Program Director of the National Screening Committee of the Public Health England (PHE), said that in 2016-2017, PHE conducted more than 21 million screenings for all diseases, and after obtaining positive screening results, more than 45,000 The person requested further examination or treatment. The United Kingdom will provide free cancer screening programs for women of different ages. For example, medical institutions will send breast cancer screening invitations to women aged 25 to 70 years old. The data for the third quarter of 2017-2018 showed that in England, the initial screening range for abdominal aortic aneurysm screening reached 62.1%, the annual monitoring screening coverage reached 92.5%, and the quarterly monitoring screening coverage reached 93.5%.

China's cancer incidence accounts for about 22% of the world's total, with a standardized incidence rate of 174.0 per 100,000. China's cancer incidence ranks 74th in the world, and the number of incidences is the world's first, while people in some regions are still shy about cancer. Chen Wanqing, director of the Office for Early Diagnosis and Early Treatment of Cancer at the National Cancer Center of China, said that China ’s cancer screening has not yet reached the universal standard in the United Kingdom because cancer screening is not covered by medical insurance, the central financial program has limited support, and focuses on eight common cancers. However, in recent years, the population coverage of cancer screening has gradually increased, basic medical training has been strengthened, and cancer screening will also be expected to be included in medical insurance.

Harrison said that 30% -50% of cancer cases are preventable, and prevention is a long-term strategy that can bring the most cost-effectiveness for cancer control. Therefore, the goal of the NHS is to significantly reduce cancer caused by inappropriate behavior, lifestyle, and environmental factors. Wu Liangyou said that in the past 10 years, the average medical cost of cancer cases in China has doubled, which is 1.3 times the per capita GDP of China. Among them, non-medical expenses account for about 10% of the total average cost. The burden cannot be ignored. The cost of diagnosis and treatment of some precancerous lesions is only 1/5 of that of cancer, and there are obvious regional differences in the cost of cancer diagnosis and treatment.

Facing a series of problems and challenges, Wu Liangyou said that China will launch a new round of action plans, including cancer risk factor control and environmental support actions, national anti-cancer and anti-cancer promotion actions, cancer prevention and treatment capacity enhancement actions, and tumor registration informatization Promoting actions, promotion of early diagnosis and treatment of cancer, promotion of standardized diagnosis and treatment of cancer, and prevention and treatment of cancer prevention, etc.